Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

TNF inhibition and sepsis — sounding a cautionary note

Conflicting results from anti-TNF trials in sepsis patients suggest that timely administration of TNF inhibitor drugs is crucial.

References

  1. 1

    Heumann D. & Glauser M.P. Pathogenesis of sepsis. Sci. Am. Med. 1, 28–37 (1994).

    CAS  Google Scholar 

  2. 2

    Dellinger, R.P. et al. From the bench to the bedside: The future of sepsis research. Chest 111, 744–753 (1997).

    Article  Google Scholar 

  3. 3

    Abraham E. et al. p55 tumor necrosis factor receptor fusion protein in the treatment of patients with severe sepsis and septic shock. A randomized controlled multicenter trial. JAMA 277, 1531–1538 (1997).

    CAS  Article  Google Scholar 

  4. 4

    Van Zee K.J. et al. Protection against lethal Escherichia coli bacteremia in baboons (Papio anubis) by pretreatment with a 55-kDa TNF receptor (CD120a)-lg fusion protein, Ro 45-2081. J. Immunol. 156, 2221–2230 (1996).

    CAS  PubMed  Google Scholar 

  5. 5

    Cohen, J., Heumann D. & Glauser M.P. Do monoclonal antibodies and anticytokines still have a future in infectious diseases. Am. J. Med. 99, 45S–52S (1995).

    CAS  Article  Google Scholar 

  6. 6

    Lesslauer, W. et al. Recombinant soluble TNF receptor proteins protect mice from LPS-induced lethality. Eur. J. Immunol. 21, 2883–2886 (1991).

    CAS  Article  Google Scholar 

  7. 7

    Munoz, C. et al. Dissociation between plasma and monocyte-associated cytokines during sepsis. Eur. J. Immunol. 21, 2177–2184 (1991).

    CAS  Article  Google Scholar 

  8. 8

    Andrejko, K.M. & Deutschman, C.S. Acute-phase gene expression correlates with intrahepatic tumor necrosis factor alpha abundance but not with plasma tumor necrosis factor concentrations during sepsis/systemic inflammatory response syndrome in the rat. Crit. Care Med. 24, 1947–1952 (1996).

    CAS  Article  Google Scholar 

  9. 9

    Pellegrini, J.D., Puyana, J.C., Lapchak, P.H., Kodys, K. & Millergraziano, C.L. A membrane TNF-alpha/TNFR ratio correlates to MODS score and mortality. Shock 6, 389–396 (1996).

    CAS  Article  Google Scholar 

  10. 10

    Wallach, D. A decade of accumulated knowledge and emerging answers. The 6th International Congress on TNF, Rhodes, Greece. May 1996. Eur. Cytokine Netw. 7, 713–724 (1996).

    CAS  PubMed  Google Scholar 

  11. 11

    Vandenabeele, P., Declercq, W., Beyaert, R. & Fiers, W. Two tumor necrosis factor receptors: Structure and function. Tr. Cell Biol. 5, 392–399 (1995).

    CAS  Article  Google Scholar 

  12. 12

    Evans, T.J. et al. Protective effect of 55-but not 75kD soluble tumor necrosis factor receptor immunoglobulin G fusion proteins in an animal model of gram-negative sepsis. J. Exp. Med. 180, 2173–2179 (1994).

    CAS  Article  Google Scholar 

  13. 13

    Kwiatkowski, D. et al. Response to monoclonal anti-TNF antibody in children with cerebral malaria. Q. J. Med. 86, 91–98 (1993)

    CAS  PubMed  Google Scholar 

  14. 14

    Brouckaert, P. et al. Inhibition of and sensitization to the lethal effects of tumor necrosis factor. J. Inflamm. 47, 18–26 (1996).

    CAS  Google Scholar 

  15. 15

    Döcke, W.D. et al. Monocyte deactivation in septic patients: Restoration by IFN-γ treatment. Nature Med. 3, 678–681 (1997).

    Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Grau, G., Maennel, D. TNF inhibition and sepsis — sounding a cautionary note. Nat Med 3, 1193–1195 (1997). https://doi.org/10.1038/nm1197-1193

Download citation

Further reading

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing